Checkpoint Neurofeedback: Standard-Protocol Courses with a Built-In Stop Rule
A brain-training service that stops treatment if the patient isn't showing measurable improvement.
A neurofeedback treatment service that delivers only the established standard protocols with proven benefit, tests processing speed at baseline and mid-course, and automatically stops and escalates the patient to other evidence-backed ADHD options if no gain appears. It is 'neurofeedback with an exit ramp' — a bounded, accountable course instead of open-ended sessions.
Concept
A specialty neurofeedback offering (in-clinic or supervised at-home EEG) built around three non-negotiable rules drawn from the newest meta-analytic evidence: (1) only established standard protocols are delivered — the protocol class that showed a small but significant benefit; (2) every patient completes a brief, standardized processing-speed test at baseline and again around session 10; (3) if processing speed has not improved, the course stops automatically and the patient is routed to the next evidence-backed option in the treatment landscape (behavior-management programs, exercise regimens, or a medication discussion with their prescriber). Families and referring clinicians buy a fixed, bounded package — e.g., a 20-session course with the mid-course checkpoint — rather than the open-ended 40-session engagements common in today's market. Providers adopt the model because it converts a treatment whose group-level evidence just took a credibility hit into one with transparent, measurable accountability.
Why now
The largest probably-blinded meta-analysis of neurofeedback to date (38 RCTs, 2,472 participants aged 5-40) found no meaningful group-level benefit on ADHD total symptoms (SMD 0.04, 95% CI -0.10 to 0.18), inattention (SMD 0.04), or hyperactivity/impulsivity (SMD 0.03) — but two signals survived: trials using established standard protocols showed a small significant benefit (SMD 0.21, 9 RCTs, n=681), and processing speed was the only neuropsychological outcome to improve (SMD 0.35, k=15, n=909), including at longer-term follow-up. The companion trial-landscape review shows non-pharmacological interventions dominate ADHD research (~80% of 695 interventional trials, 1999-2021), with behavior management the most-studied psychological option (115 studies) — giving the service a concrete, evidence-ranked escalation path when the checkpoint fails. Together the two papers define exactly which protocol class to deliver, which single measure to track, and where to send non-responders.
Written by GLM · 12 Oct 2026
AI assessment
A high-integrity service model that transforms a controversial treatment into a transparent, bounded product by using a specific neuropsychological marker as a hard stop-rule.
- Evidence strength 5/5
- The idea maps precisely to the meta-analysis results: it uses the only protocol class with significant benefit and the only neuropsychological outcome (processing speed) that showed improvement.
- Market pull 4/5
- There is strong demand from parents and clinicians for accountability in neurofeedback, and the 'exit ramp' reduces the financial and emotional risk of ineffective treatment.
- Novelty & moat 4/5
- While other ideas focus on measurement batteries, this is the first to use that data as a structural 'stop-loss' mechanism to pivot patients to other evidence-backed therapies.
- Feasibility 5/5
- The MVP requires no new technology, only the implementation of a specific clinical protocol and a standardized processing-speed test.
- Wedge clarity 5/5
- The 'bounded 20-session course with a mid-point checkpoint' is a sharp, sellable product that differentiates itself from open-ended clinic models.
- Simplicity / focus 5/5
- The idea is a single, focused service offering with a clear operational rule rather than a complex platform.
Scored by Gemma 4 · 12 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.
Persona discussion
AI personas trained on real people's expertise debate this idea as it evolves.
View the discussion →Act on this idea
Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.
Who benefits
- Peak Brain Institutescompany
Operates consumer neurofeedback; adopting checkpointed, standard-protocol-only courses lets it retain client trust and clinician referrals after a headline null meta-analysis, and the stop rule prevents wasted-session disputes.
- NeuroCare Groupcompany
Runs neurofeedback clinic networks in Europe and Australia; a standardized stop-and-escalate model differentiates its clinics and aligns delivery with the only protocol class that showed benefit.
- CHADDorganization
The national ADHD patient-advocacy organization needs concrete guidance for families asking whether to try neurofeedback; a checkpoint standard ('standard protocol, measurable processing-speed gain, or stop') is actionable advice it can publish.
- ADDitude Magazinecompany
Publishes treatment guidance to ADHD families; the checkpoint framework converts a confusing, contradictory evidence picture into a clear consumer decision rule for its audience.
Research it builds on
- Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trialsVictoria A. Nazarova, Aleksandr V. Sokolov, Vladimir N. Chubarev et al. · 2022 · 108 citationsAll ideas from this paper →
- Neurofeedback for Attention-Deficit/Hyperactivity DisorderSamuel James Westwood, Pascal-M. Aggensteiner, Anna Kaiser et al. · 2024 · 42 citationsAll ideas from this paper →